[{"orgOrder":0,"company":"SyneuRx","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"U.S.A","productType":"Miscellaneous","year":"2013","type":"Inapplicable","leadProduct":"Sodium Benzoate","moa":"Amino acid metabolism","graph1":"Psychiatry\/Psychology","graph2":"Phase II\/ Phase III","graph3":"SyneuRx","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Tablet","sponsorNew":"SyneuRx \/ Undisclosed","highestDevelopmentStatusID":"9","companyTruncated":"SyneuRx \/ Undisclosed"},{"orgOrder":0,"company":"SyneuRx","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"U.S.A","productType":"Miscellaneous","year":"2014","type":"Inapplicable","leadProduct":"Sodium Benzoate","moa":"Amino acid metabolism","graph1":"Psychiatry\/Psychology","graph2":"Phase II\/ Phase III","graph3":"SyneuRx","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Tablet","sponsorNew":"SyneuRx \/ Undisclosed","highestDevelopmentStatusID":"9","companyTruncated":"SyneuRx \/ Undisclosed"},{"orgOrder":0,"company":"SyneuRx","sponsor":"Amarex Clinical Research","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"U.S.A","productType":"Miscellaneous","year":"2017","type":"Inapplicable","leadProduct":"Sodium Benzoate","moa":"Amino acid metabolism","graph1":"Psychiatry\/Psychology","graph2":"Phase II\/ Phase III","graph3":"SyneuRx","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"SyneuRx \/ Amarex Clinical Research","highestDevelopmentStatusID":"9","companyTruncated":"SyneuRx \/ Amarex Clinical Research"},{"orgOrder":0,"company":"SyneuRx","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"U.S.A","productType":"Miscellaneous","year":"2021","type":"Inapplicable","leadProduct":"Pentarlandir","moa":"TMPRSS2","graph1":"Infections and Infectious Diseases","graph2":"Phase II","graph3":"SyneuRx","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Capsule","sponsorNew":"SyneuRx \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"SyneuRx \/ Undisclosed"},{"orgOrder":0,"company":"SyneuRx","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"U.S.A","productType":"Miscellaneous","year":"2022","type":"Inapplicable","leadProduct":"Pentarlandir","moa":"TMPRSS2","graph1":"Infections and Infectious Diseases","graph2":"Phase II","graph3":"SyneuRx","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Capsule","sponsorNew":"SyneuRx \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"SyneuRx \/ Undisclosed"},{"orgOrder":0,"company":"SyneuRx","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"U.S.A","productType":"Miscellaneous","year":"2022","type":"Inapplicable","leadProduct":"Pentarlandir","moa":"TMPRSS2","graph1":"Infections and Infectious Diseases","graph2":"Phase II","graph3":"SyneuRx","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Capsule","sponsorNew":"SyneuRx \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"SyneuRx \/ Undisclosed"}]